Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
The U.S. Food and Drug Administration's accelerated approval program is supposed to offer sufferers early entry to promising drugs. But ...
The U.S. Food and Drug Administration's accelerated approval program is supposed to offer sufferers early entry to promising drugs. But ...
